Association Between Number of Endoscopic Resections and Utilization of Bacillus Calmette-Guérin Therapy for Patients With High-Grade, Non–Muscle-Invasive Bladder Cancer-Reference-Cited by-同舟云学术

Association Between Number of Endoscopic Resections and Utilization of Bacillus Calmette-Guérin Therapy for Patients With High-Grade, Non–Muscle-Invasive Bladder Cancer

Published:2017-02 Issue:1 Volume:15 Page:e25-e31
ISSN:1558-7673
Container-title:Clinical Genitourinary Cancer
language:en
Short-container-title:Clinical Genitourinary Cancer

Author:

Lenis Andrew T.,Donin Nicholas M.,Litwin Mark S.,Saigal Christopher S.,Lai Julie,Hanley Jan M.,Konety Badrinath R.,Chamie Karim

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference29 articles.

1. Urothelial tumors of the bladder;Wood,2010

2. Recurrence of high-risk bladder cancer: a population-based analysis;Chamie;Cancer,2013

3. Treatment and survival in patients with recurrent high-risk non–muscle-invasive bladder cancer;Chamie;Urol Oncol,2015

4. Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer: a meta-analysis of the published results of randomized clinical trials;Sylvester;J Urol,2002

5. Can intravesical bacillus Calmette-Guérin reduce recurrence in patients with superficial bladder cancer? A meta-analysis of randomized trials;Han;Urology,2006

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment Outcomes of High-Risk Non-Muscle Invasive Bladder Cancer (HR-NMIBC) in Real-World Evidence (RWE) Studies: Systematic Literature Review (SLR);ClinicoEconomics and Outcomes Research;2022-01

2. Clinical Case Debate: Neoadjuvant Checkpoint Inhibition Versus Standard Chemotherapy;Neoadjuvant Immunotherapy Treatment of Localized Genitourinary Cancers;2022

3. Intermediate- and high-risk nonmuscle invasive bladder cancer: Where do we stand?;Urologic Oncology: Seminars and Original Investigations;2021-10

4. Identification of a Novel Inflamed Tumor Microenvironment Signature as a Predictive Biomarker of Bacillus Calmette-Guérin Immunotherapy in Non–Muscle-Invasive Bladder Cancer;Clinical Cancer Research;2021-06-11

5. Real World Outcomes of Patients with Bladder Cancer;Hematology/Oncology Clinics of North America;2021-06